fbpx

MiniMed™ 630G Insulin Pump System

MiniMed™ 630G Insulin Pump System

Simplify insulin delivery with the MiniMed 630G Insulin Pump System. Medtronic’s MiniMed pumps are the only devices on the market with SmartGuard, a technology made to step in when your glucose levels go under a predetermined level.* You’ll also get predictive alerts of high or low glucose trends up to half an hour in advance.

Thanks to these features, MiniMed 630G System users may find it easier to stay in range† and reach their target A1C.‡

Please call our Customer Care Team at 1-866-422-4866 or fill out the form below to see if you qualify for an insulin pump system with $0 out-of-pocket costs.

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

Description

Along with delivering insulin, the MiniMed 630G System works with Medtronic’s Guardian Sensor 3 and Guardian Link 3 Transmitter to offer optional CGM capabilities. It can also calculate and recommend bolus doses.

At the heart of this system is the MiniMed 630G Insulin Pump itself. This device is easy to use, waterproof§, and even has an airplane mode for frequent flyers. While wearing this pump, you’ll be able to live life without worrying about insulin doses – and its tubing only needs to be changed once every two to three days.

Features

  • SmartGuard technology can respond to low glucose levels*
  • Color screen with automatic brightness adjustments
  • Simple for anyone to use
  • Guardian Sensor 3 adds optional CGM
  • Sensor is wearable for up to seven days

Uses

The MiniMed 630G Insulin Pump System can automatically deliver insulin to people with type 1 or type 2 diabetes. Along with this, it can offer CGM capabilities when paired with other products from Medtronic

MiniMed™ 630G Insulin Pump System Video

FAQs

The SmartGuard system takes action when your glucose levels dip below a certain point. If you don’t respond to alerts, the system can pause insulin delivery for up to two hours.¶

The MiniMed 630G System does not have integrated CGM capabilities. However, it can work with the Guardian Sensor 3 and Guardian Link 3 Transmitter to provide CGM features to its users.

According to Medtronic, this system can lower users’ risk of complications related to kidney damage, nerve damage, cardiovascular damage, and eye damage.#

When used with the Guardian Sensor 3 and Guardian Link 3 Transmitter, the MiniMed 630G System can deliver updated glucose readings every five minutes.

*CGM uses a special sensor to measure sugar levels just below the skin known as interstitial fluid. These sensor glucose (SG) values are different from blood glucose (BG) measurements using a BG meter. Sensor glucose values should not be used to make treatment decisions. Patients should always do a BG fingerstick before they make treatment decisions.

†Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomized controlled trial. Diabetologia. 2012;55:3155–3162.

‡Doyle EA, Weinzimer SA, Steffen AT, Ahern JAH, Vincent M, Tamborlane WV. A randomized prospective trial comparing the efficacy of insulin pump therapy with multiple daily injections using insulin glargine. Diabetes Care. 2004;27(7):1554–1558.

§At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours.

¶Refers to suspend on low. WARNING: Do not use the Suspend on low feature to prevent or treat low glucose. Always confirm your sensor glucose reading using your BG meter, and follow the instructions of your healthcare professional to treat low glucose. Using Suspend on low alone to prevent or treat low glucose may result in prolonged hypoglycemia.

#The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.